Dallas K. Croom

911 total citations
16 papers, 687 citations indexed

About

Dallas K. Croom is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Dallas K. Croom has authored 16 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 6 papers in Oncology. Recurrent topics in Dallas K. Croom's work include Neuropeptides and Animal Physiology (7 papers), Peptidase Inhibition and Analysis (4 papers) and Diabetes Treatment and Management (4 papers). Dallas K. Croom is often cited by papers focused on Neuropeptides and Animal Physiology (7 papers), Peptidase Inhibition and Analysis (4 papers) and Diabetes Treatment and Management (4 papers). Dallas K. Croom collaborates with scholars based in United States and China. Dallas K. Croom's co-authors include James M. Lenhard, James E. Weiel, Dana T. Minnick, Deborah A. Winegar, Michael K. James, Elizabeth E. Sugg, Michael F. Johnson, Mary K. Grizzle, R. W. Dougherty and Gregory N. Ervin and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Journal of Nutrition.

In The Last Decade

Dallas K. Croom

16 papers receiving 659 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dallas K. Croom United States 15 313 165 159 141 128 16 687
Ulrike Gutjahr Germany 15 234 0.7× 505 3.1× 30 0.2× 69 0.5× 27 0.2× 15 759
Peter J.S. Chiu United States 17 239 0.8× 154 0.9× 99 0.6× 78 0.6× 38 0.3× 34 776
Sonia M. de Morais United States 12 257 0.8× 611 3.7× 69 0.4× 16 0.1× 25 0.2× 17 998
Simone Kowalewski Germany 10 172 0.5× 353 2.1× 20 0.1× 61 0.4× 25 0.2× 10 566
Frank W. Lee United States 13 173 0.6× 184 1.1× 21 0.1× 110 0.8× 36 0.3× 21 698
Nahal Ketabi‐Kiyanvash Germany 9 112 0.4× 415 2.5× 24 0.2× 15 0.1× 7 0.1× 9 708
Shane Roller United States 12 143 0.5× 39 0.2× 62 0.4× 33 0.2× 92 0.7× 24 359
Yuichi Sugiyama Japan 13 249 0.8× 700 4.2× 29 0.2× 15 0.1× 12 0.1× 21 951
Khuraijam Dhanachandra Singh India 14 315 1.0× 45 0.3× 50 0.3× 109 0.8× 60 0.5× 38 685
Jessica Bo Li Lu United States 12 100 0.3× 53 0.3× 41 0.3× 21 0.1× 7 0.1× 30 321

Countries citing papers authored by Dallas K. Croom

Since Specialization
Citations

This map shows the geographic impact of Dallas K. Croom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dallas K. Croom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dallas K. Croom more than expected).

Fields of papers citing papers by Dallas K. Croom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dallas K. Croom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dallas K. Croom. The network helps show where Dallas K. Croom may publish in the future.

Co-authorship network of co-authors of Dallas K. Croom

This figure shows the co-authorship network connecting the top 25 collaborators of Dallas K. Croom. A scholar is included among the top collaborators of Dallas K. Croom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dallas K. Croom. Dallas K. Croom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Chen, Lihong, Xiaozhou Yao, Andrew Young, et al.. (2011). Inhibition of apical sodium-dependent bile acid transporter as a novel treatment for diabetes. American Journal of Physiology-Endocrinology and Metabolism. 302(1). E68–E76. 88 indexed citations
2.
Haffner, Curt D., Darryl McDougald, Brian Thompson, et al.. (2005). 2-Cyano-4-fluoro-1-thiovalylpyrrolidine analogues as potent inhibitors of DPP-IV. Bioorganic & Medicinal Chemistry Letters. 15(23). 5257–5261. 20 indexed citations
3.
Lenhard, James M., Dallas K. Croom, & Dana T. Minnick. (2004). Reduced serum dipeptidyl peptidase-IV after metformin and pioglitazone treatments. Biochemical and Biophysical Research Communications. 324(1). 92–97. 82 indexed citations
4.
Haffner, Curt D., James M. Lenhard, Aaron B. Miller, et al.. (2004). Structure-Based Design of Potent Retinoid X Receptor α Agonists. Journal of Medicinal Chemistry. 47(8). 2010–2029. 40 indexed citations
5.
Sherrill, Ronald G., Judd Berman, Dallas K. Croom, et al.. (2001). 1,4-Benzodiazepine Peripheral Cholecystokinin (CCK-A) Receptor Agonists. Bioorganic & Medicinal Chemistry Letters. 11(9). 1145–1148. 22 indexed citations
6.
Croom, Dallas K., et al.. (2000). Dietary Fat Alters HIV Protease Inhibitor–Induced Metabolic Changes in Mice. Journal of Nutrition. 130(9). 2361–2366. 23 indexed citations
7.
Lenhard, James M., Dallas K. Croom, James E. Weiel, & Deborah A. Winegar. (2000). HIV Protease Inhibitors Stimulate Hepatic Triglyceride Synthesis. Arteriosclerosis Thrombosis and Vascular Biology. 20(12). 2625–2629. 106 indexed citations
8.
Henke, Brad R., Christopher Aquino, Larry S. Birkemo, et al.. (1997). Optimization of 3-(1H-Indazol-3-ylmethyl)-1,5-benzodiazepines as Potent, Orally Active CCK-A Agonists. Journal of Medicinal Chemistry. 40(17). 2706–2725. 63 indexed citations
9.
Shaver, Sammy R., William Pendergast, Suhaib M. Siddiqi, et al.. (1997). 4-Substituted Uridine 5′-Triphosphates as Agonists of the P2Y2Purinergic Receptor. Nucleosides and Nucleotides. 16(7-9). 1099–1102. 8 indexed citations
10.
Willson, Timothy M., Brad R. Henke, Peter L. Myers, et al.. (1996). 3-[2-(N-Phenylacetamide)]-1,5-benzodiazepines:  Orally Active, Binding Selective CCK-A Agonists. Journal of Medicinal Chemistry. 39(15). 3030–3034. 18 indexed citations
11.
Henke, Brad R., Timothy M. Willson, Elizabeth E. Sugg, et al.. (1996). 3-(1H-Indazol-3-ylmethyl)-1,5-benzodiazepines:  CCK-A Agonists That Demonstrate Oral Activity as Satiety Agents. Journal of Medicinal Chemistry. 39(14). 2655–2658. 20 indexed citations
12.
Hirst, Gavin C., Christopher Aquino, Dallas K. Croom, et al.. (1996). Discovery of 1,5-Benzodiazepines with Peripheral Cholecystokinin (CCK-A) Receptor Agonist Activity (II):  Optimization of the C3 Amino Substituent. Journal of Medicinal Chemistry. 39(26). 5236–5245. 31 indexed citations
13.
Aquino, Christopher, Duncan Armour, Judd Berman, et al.. (1996). Discovery of 1,5-Benzodiazepines with Peripheral Cholecystokinin (CCK-A) Receptor Agonist Activity. 1. Optimization of the Agonist “Trigger”. Journal of Medicinal Chemistry. 39(2). 562–569. 79 indexed citations
14.
Lackey, Karen, Daniel D. Sternbach, Dallas K. Croom, et al.. (1996). Water Soluble Inhibitors of Topoisomerase I:  Quaternary Salt Derivatives of Camptothecin. Journal of Medicinal Chemistry. 39(3). 713–719. 25 indexed citations
15.
Dezube, Milana, Elizabeth E. Sugg, Larry S. Birkemo, et al.. (1995). Modification of Receptor Selectivity and Functional Activity in Cholecystokinin Peptoid Ligands. Journal of Medicinal Chemistry. 38(17). 3384–3390. 16 indexed citations
16.
Uehling, David, et al.. (1995). Synthesis, Topoisomerase I Inhibitory Activity, and in Vivo Evaluation of 11-Azacamptothecin Analogs. Journal of Medicinal Chemistry. 38(7). 1106–1118. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ulrike Gutjahr Breakdown of academic impact, for papers by Peter J.S. Chiu Breakdown of academic impact, for papers by Sonia M. de Morais Breakdown of academic impact, for papers by Simone Kowalewski Breakdown of academic impact, for papers by Frank W. Lee Breakdown of academic impact, for papers by Nahal Ketabi‐Kiyanvash Breakdown of academic impact, for papers by Shane Roller Breakdown of academic impact, for papers by Yuichi Sugiyama Breakdown of academic impact, for papers by Khuraijam Dhanachandra Singh Breakdown of academic impact, for papers by Jessica Bo Li Lu
Rankless by CCL
2026